What is Duncan?
Duncan & Todd Group operates as a premier provider of optical and hearing solutions, boasting a legacy that spans over five decades. The company distinguishes itself through a dual-pronged business model: a widespread retail network comprising more than 40 branches and a sophisticated, multi-million-pound ophthalmic lens manufacturing laboratory. This vertical integration allows the group to maintain stringent quality control while providing personalized care to a diverse patient base. By combining clinical expertise with high-end manufacturing capabilities, the firm effectively bridges the gap between diagnostic healthcare and retail consumerism, securing a dominant market share in Scotland's specialized medical services sector.
How much funding has Duncan raised?
Duncan has raised a total of $9.3M across 2 funding rounds:
Other Financing Round
$3.9M
Unspecified
$5.4M
Other Financing Round (2013): $3.9M with participation from BGF and Business Growth Fund
Unspecified (2015): $5.4M led by Business Growth Fund
Key Investors in Duncan
Business Growth Fund
BGF is a prominent UK-based investment firm that provides long-term capital to small and mid-sized businesses, acting as a catalyst for growth across diverse economic sectors.
What's next for Duncan?
Looking ahead, the strategic deployment of the $5.4M capital is expected to catalyze further modernization of the group's retail infrastructure and manufacturing processes. As the healthcare sector increasingly shifts toward integrated, technology-driven patient experiences, Duncan & Todd Group is poised to capitalize on its existing scale to implement advanced diagnostic tools and digital patient management systems. The firm's trajectory suggests a continued focus on organic growth and potential service diversification, reinforcing its status as a vital healthcare partner for communities throughout Scotland. By maintaining its commitment to clinical excellence and operational efficiency, the group is prepared to navigate the evolving demands of the optical and audiology markets with sustained financial stability.
See full Duncan company page
